The Inhibin A Test is a blood test that measures levels of the hormone inhibin A, which is produced by the ovaries in females and plays a critical role in reproductive health.
This INHIBIN A test is commonly used in prenatal screening to assess fetal health and risk factors and as a tumor marker for ovarian cancer. The Inhibin A test in pregnancy is often part of a broader screening protocol, known as the quadruple test, which helps identify the likelihood of chromosomal abnormalities in the fetus.
The Inhibin A Test measures the amount of inhibin A hormone in the blood. Inhibin A is produced primarily by ovarian follicles, with varying levels depending on age, menstrual cycle, and pregnancy. This test is useful in pregnancy to assess risks for conditions like Down syndrome. In postmenopausal women and individuals with ovarian tumors, Inhibin A levels can be elevated, making it a useful marker for ovarian cancer diagnosis and monitoring.
The Inhibin A test normal levels vary depending on age, sex, and specific health conditions:
Non-Pregnant Women: Normal inhibin A levels typically range between 5-50 pg/mL but vary widely.
Pregnant Women: Normal levels increase with gestation weeks, with ranges differing according to each trimester.
Postmenopausal Women: Inhibin A levels are generally lower but can be elevated in the case of ovarian tumors.
These ranges may differ depending on individual factors, lab standards, and methodologies.
The Inhibin A test is conducted by drawing a blood sample from the arm. The procedure is straightforward and involves:
Preparation:
Fasting is usually not required unless specified by the healthcare provider.
Blood Collection:
A healthcare professional draws a blood sample from a vein in the arm.
Laboratory Analysis: The blood sample is then sent to a laboratory for analysis, where inhibin A levels are measured.,br> Results are typically available within a few days, depending on the laboratory’s processing time.
The Inhibin A Test is recommended for specific groups:
Pregnant Women: Especially those in their second trimester as part of the quadruple screening test to assess the risk of fetal chromosomal abnormalities, such as Down syndrome.
Women at Risk of Ovarian Cancer: This includes women with a family history of ovarian cancer or related symptoms. The Inhibin A test for ovarian cancer can help in diagnosis and monitoring response to treatment.
Older Women: As ovarian cancer risk increases with age, women over 50, or those experiencing symptoms, may be advised to take this test.
Diagnopein provides quality diagnostics with high standards of care, making it a preferred choice for the Inhibin A Test. Here’s why:
Clean and Hygienic Facilities: We maintain the highest standards of cleanliness, providing a safe environment for all patients.
Affordable Testing: Diagnopein offers competitive pricing for advanced diagnostic tests like the Inhibin A Test.
Experienced Staff: Our skilled healthcare professionals ensure each sample is handled precisely.
Advanced Technology: Diagnopein uses state-of-the-art testing equipment for highly accurate and reliable diagnostics.
This test measures levels of inhibin A in the blood and is commonly part of prenatal screening to assess the risk of fetal abnormalities like Down syndrome.
High levels of inhibin A may suggest the presence of ovarian cancer and can be used to monitor treatment responses.
Normal levels vary by age, pregnancy status, and other factors. Pregnant women typically have higher inhibin A levels depending on the stage of gestation.
While both measure related hormones produced by the ovaries, Inhibin B is more often associated with ovarian reserve and fertility assessments, whereas Inhibin A is primarily used for prenatal screening and as a tumor marker.
No, it is usually recommended for those at higher risk of chromosomal abnormalities or as part of a broader prenatal screening panel.
Elevated levels may be associated with ovarian tumors and warrant further investigation by a healthcare provider.
